| Literature DB >> 30274224 |
Ivan Malík1, Jozef Csöllei2, Ivan Solovič3,4, Šárka Pospíšilová5, Hana Michnová6, Josef Jampílek7, Alois Čížek8, Iva Kapustíková9, Jana Čurillová10, Mária Pecháčová11, Jiřina Stolaříková12, Daniel Pecher13,14, Michal Oravec15.
Abstract
In order to provide a more detailed view on the structure⁻antimycobacterial activity relationship (SAR) of phenylcarbamic acid derivatives containing two centers of protonation, 1-[2-[({[2-/3-(Entities:
Keywords: Mycobacterium spp.; dibasic phenylcarbamates; electronic properties; lipophilicity; surface tension
Mesh:
Substances:
Year: 2018 PMID: 30274224 PMCID: PMC6222509 DOI: 10.3390/molecules23102493
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structure of thioridazine (a), a neuroleptic drug containing a phenothiazine scaffold (a); as well as effective local anesthetics (b) lidocaine (xylocaine); and (c) dibucaine (cinchocaine). All these compounds showed notable in vitro efficiency against some mycobacterial strains [5,6,7,8,9,10,11,12]. Structural fragments of dibucaine were color-coded as follows: a lipophilic moiety (a dark green framework), polar group (orange), connecting hydrocarbon chain (gray) and salt-forming (basic) group (dark red), respectively.
Chemical structure of evaluated compounds 1a–p, their surface tension γ (relative surface activity; in N/m units), wavelengths of observed absorption maxima (λ1, λ2 (Ch-T), λ3) and logarithms of molar absorption coefficients (log ε1, log ε2 (Ch-T), log ε3) of compounds’ methanolic solutions (c = 8.0 × 10−5 M), which were investigated in the UV/Vis region of an electromagnetic spectrum.
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Comp. |
|
|
| γ (N/m) |
| log |
| 1 log |
| log |
|
| 2-OC4H9 | A | C | 0.06464 | 208 | 4.51 | 236 | 4.19 | 280 | 3.63 |
|
| 2-OC5H11 | A | C | 0.06366 | 208 | 4.39 | 236 | 4.05 | 280 | 3.51 |
|
| 2-OC6H13 | A | C | 0.06222 | 208 | 4.58 | 238 | 4.52 | 278 | 3.49 |
|
| 2-OC7H15 | A | C | 0.05985 | 208 | 4.43 | 236 | 4.08 | 280 | 3.55 |
|
| 3-OC4H9 | A | D | 0.06316 | 210 | 4.65 | 238 | 4.24 | 279 | 3.59 |
|
| 3-OC5H11 | A | D | 0.06285 | 210 | 4.55 | 237 | 4.27 | 279 | 3.62 |
|
| 3-OC6H13 | A | D | 0.06105 | 210 | 4.54 | 237 | 4.13 | 279 | 3.48 |
|
| 3-OC7H15 | A | D | 0.05786 | 210 | 4.66 | 237 | 4.27 | 279 | 3.63 |
|
| 2-OC4H9 | B | C | 0.06302 | 208 | 4.44 | 236 | 4.08 | 280 | 3.57 |
|
| 2-OC5H11 | B | C | 0.06206 | 208 | 4.54 | 236 | 4.22 | 280 | 3.71 |
|
| 2-OC6H13 | B | C | 0.06065 | 208 | 4.42 | 236 | 4.10 | 280 | 3.57 |
|
| 2-OC7H15 | B | C | 0.05853 | 208 | 4.44 | 236 | 4.14 | 280 | 3.59 |
|
| 3-OC4H9 | B | D | 0.06298 | 210 | 4.52 | 238 | 4.09 | 279 | 3.44 |
|
| 3-OC5H11 | B | D | 0.06154 | 210 | 4.56 | 238 | 4.18 | 279 | 3.52 |
|
| 3-OC6H13 | B | D | 0.05925 | 210 | 4.52 | 238 | 4.01 | 279 | 3.37 |
|
| 3-OC7H15 | B | D | 0.05692 | 210 | 4.65 | 238 | 4.20 | 279 | 3.56 |
1 log ε2 (Ch-T), Logarithms of molar absorption coefficients observed at the charge-transfer absorption maximum λ2 (Ch-T) = 236–238 nm.
Scheme 1Synthesis of 1-[2-[({[2-/3-(alkoxy)phenyl]amino}carbonyl)oxy]-3-(dipropylammonio)-propyl]pyrrolidinium/azepanium oxalates/dichlorides (1a–p; alkoxy = butoxy to heptyloxy). Reagents and conditions: (i) (CH3CO)2O, reflux (1h); (ii) Na, anhydrous EtOH, 1-bromoalkane (alkane = butane to heptane), r.t. (12h), reflux (3h); (iii) 18% HCl, reflux (2h); (iv) phosgene, anhydrous toluene, reflux (3h); (v) (±)-2-(chloromethyl)oxirane, 35 °C (2h), r.t. (48h), 38% NaOH; (vi) pyrrolidine/azepane, anhydrous 2-PrOH, reflux (6h); (vii) anhydrous toluene, reflux (8h); (viii) saturated solution of (a) oxalic acid in anhydrous EtOH or (b) ethereal hydrogen chloride.
Figure 2Relationships between number of carbon atoms forming the 2-/3-alkoxy side chain R (nc; alkoxy = butoxy to heptyloxy) and γ values (in N/m units) of the compounds 1a–p.
Figure 3Chemical structure of the compounds JC-01a–l, effective local anesthetics [33], which were able to decrease surface tension of water [34].
Retention times tr (RP-HPLC) and lipophilicity indices log k (RP-HPLC) of the compounds 1a–p estimated in the mobile phases with a various volume ratio (v/v) of a methanol (MeOH) organic modifier and water.
| Comp. | Mobile Phase MeOH/Water ( | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 80:20 | 85:15 | 90:10 | 95:5 | Pure MeOH | ||||||
| log | log | log | log | log | ||||||
|
| 13.883 | 0.7165 | 10.694 | 0.5756 | 7.830 | 0.3958 | 5.766 | 0.2008 | 4.224 | −0.0403 |
|
| 17.200 | 0.8254 | 12.647 | 0.6656 | 9.449 | 0.5064 | 6.514 | 0.2841 | 4.526 | 0.0203 |
|
| 25.694 | 1.0206 | 16.950 | 0.8162 | 11.292 | 0.6053 | 7.431 | 0.3683 | 5.246 | 0.1287 |
|
| 31.000 | 1.1092 | 19.600 | 0.8882 | 13.553 | 0.7022 | 7.892 | 0.4052 | 5.385 | 0.1573 |
|
| 10.330 | 0.5584 | 6.917 | 0.3183 | 5.400 | 0.1478 | 3.822 | −0.1454 | 3.329 | −0.2956 |
|
| 12.400 | 0.6574 | 9.200 | 0.4911 | 6.280 | 0.2546 | 4.022 | −0.0941 | 3.340 | −0.2913 |
|
| 17.200 | 0.8254 | 11.402 | 0.6104 | 7.483 | 0.3679 | 5.153 | 0.1182 | 3.583 | −0.2067 |
|
| 22.003 | 0.9521 | 13.701 | 0.7159 | 8.532 | 0.4565 | 5.788 | 0.2092 | 3.556 | −0.2153 |
|
| 24.020 | 0.9881 | 16.917 | 0.8153 | 11.691 | 0.6240 | 7.765 | 0.3954 | 5.127 | 0.1205 |
|
| 29.525 | 1.0863 | 20.021 | 0.8981 | 13.060 | 0.6828 | 8.520 | 0.4509 | 5.295 | 0.1449 |
|
| 47.108 | 1.3023 | 27.001 | 1.0424 | 16.533 | 0.8038 | 9.641 | 0.5221 | 6.938 | 0.3303 |
|
| 70.012 | 1.4831 | 38.800 | 1.2152 | 22.636 | 0.9619 | 11.670 | 0.6271 | 7.756 | 0.3996 |
|
| 15.731 | 0.7805 | 9.218 | 0.4922 | 6.420 | 0.2695 | 4.685 | 0.0424 | 3.519 | −0.2275 |
|
| 22.183 | 0.9502 | 12.370 | 0.6542 | 8.156 | 0.4205 | 4.995 | 0.0941 | 3.947 | −0.1047 |
|
| 29.174 | 1.0807 | 13.651 | 0.7059 | 9.634 | 0.5174 | 5.095 | 0.1095 | 4.127 | −0.0618 |
|
| 33.719 | 1.1484 | 17.129 | 0.8215 | 11.332 | 0.6072 | 5.801 | 0.2051 | 3.925 | −0.1102 |
Extrapolated log kw parameters (RP-HPLC) of analyzed molecules 1a–p and values of statistical descriptors (χ2red, RSS, R, Adj. R2, RMSE, NR, F and Prob > F), which characterized a linear relationship between the log k and ϕM values for a particular compound. The ϕM parameter was a volume fraction of MeOH in the isocratic elution RP-HPLC.
| Comp. | log |
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
|---|---|---|---|---|---|---|---|---|---|---|
|
| 3.7688 | 3.7768 | 0.0011 | 0.0034 | 0.9953 | 0.9875 | 0.0335 | 0.0580 | 317.64 | 0.0001 *** |
|
| 4.0454 | 3.9834 | 0.0018 | 0.0055 | 0.9931 | 0.9817 | 0.0429 | 0.0744 | 215.17 | 0.0007 *** |
|
| 4.6049 | 4.4634 | 0.0002 | 0.0007 | 0.9993 | 0.9982 | 0.0152 | 0.0263 | 2155.37 | 0.0001 *** |
|
| 4.9487 | 4.7736 | 0.0011 | 0.0033 | 0.9971 | 0.9923 | 0.0332 | 0.0574 | 518.15 | 0.0002 *** |
|
| 4.0258 | 4.3434 | 0.0013 | 0.0038 | 0.9960 | 0.9894 | 0.0354 | 0.0614 | 375.47 | 0.0003 *** |
|
| 4.6722 | 4.9652 | 0.0028 | 0.0084 | 0.9932 | 0.9821 | 0.0530 | 0.0917 | 219.79 | 0.0007 *** |
|
| 4.9446 | 5.1128 | 0.0013 | 0.0040 | 0.9969 | 0.9919 | 0.0366 | 0.0634 | 487.75 | 0.0002 *** |
|
| 5.5384 | 5.6830 | 0.0042 | 0.0126 | 0.9923 | 0.9795 | 0.0648 | 0.1122 | 192.51 | 0.0008 *** |
|
| 4.4679 | 4.3102 | 0.0014 | 0.0042 | 0.9955 | 0.9879 | 0.0376 | 0.0652 | 328.27 | 0.0004 *** |
|
| 4.8466 | 4.6600 | 0.0016 | 0.0048 | 0.9956 | 0.9882 | 0.0401 | 0.0695 | 337.19 | 0.0004 *** |
|
| 5.2359 | 4.9286 | 0.0005 | 0.0017 | 0.9987 | 0.9964 | 0.0234 | 0.0406 | 1106.57 | 0.0001 *** |
|
| 5.8966 | 5.5102 | 0.0007 | 0.0020 | 0.9988 | 0.9965 | 0.0259 | 0.0449 | 1127.92 | 0.0001 *** |
|
| 4.7099 | 4.9316 | 0.0004 | 0.0013 | 0.9990 | 0.9972 | 0.0205 | 0.0356 | 1442.73 | 0.0001 *** |
|
| 5.2087 | 5.3398 | 0.0011 | 0.0032 | 0.9978 | 0.9941 | 0.0325 | 0.0564 | 673.05 | 0.0001 *** |
|
| 5.6569 | 5.7628 | 0.0045 | 0.0134 | 0.9920 | 0.9789 | 0.0668 | 0.1157 | 186.23 | 0.0009 *** |
|
| 6.1749 | 6.2672 | 0.0022 | 0.0067 | 0.9966 | 0.9909 | 0.0474 | 0.0820 | 438.042 | 0.0001 *** |
1S, Slope; 2χ2red, reduced chi-square; 3RSS, residual sum of squares; 4R, correlation coefficient; 5Adj. R2, adjusted coefficient of determination; 6RMSE, root mean squared error (standard deviation); 7NR, norm of residuals; 8F, Fisher’s significance ratio (Fisher’s F-test); 9Prob > F, probability of obtaining the F Ratio (significance of a whole model). Indication of a significance level of the F Ratio was as follows: *** (three stars), extremely significant.
Values of logarithms of partition coefficients of basic (non-protonated) compounds 9′a–p predicted for the octan-1-ol/water partitioning system by the Ghose and Crippen′s approach (log PCr), Viswanadhan′s principle (log PV), Broto′s algorithm (log PB) and CLOGP method (CLOGP 4.0), respectively, as well as by both XLOGP approaches (XLOGP 2.0 and XLOGP 3.0).
|
| ||||||||
|---|---|---|---|---|---|---|---|---|
| Comp. |
|
| log | log | log | CLOGP | XLOGP | XLOGP |
|
| 2-OC4H9 | A | 4.59 | 4.45 | 4.51 | 6.23 | 4.52 | 5.14 |
|
| 2-OC5H11 | A | 5.00 | 4.85 | 4.97 | 6.76 | 5.09 | 5.68 |
|
| 2-OC6H13 | A | 5.42 | 5.24 | 5.42 | 7.29 | 5.66 | 6.22 |
|
| 2-OC7H15 | A | 5.84 | 5.64 | 5.88 | 7.82 | 6.23 | 6.77 |
|
| 3-OC4H9 | A | 4.59 | 4.45 | 4.51 | 6.23 | 4.52 | 5.14 |
|
| 3-OC5H11 | A | 5.00 | 4.85 | 4.97 | 6.76 | 5.09 | 5.68 |
|
| 3-OC6H13 | A | 5.42 | 5.24 | 5.42 | 7.29 | 5.66 | 6.22 |
|
| 3-OC7H15 | A | 5.84 | 5.64 | 5.88 | 7.82 | 6.23 | 6.77 |
|
| 2-OC4H9 | B | 5.42 | 5.24 | 5.42 | 7.35 | 5.24 | 5.86 |
|
| 2-OC5H11 | B | 5.84 | 5.64 | 5.88 | 7.88 | 5.81 | 6.40 |
|
| 2-OC6H13 | B | 6.26 | 6.04 | 6.33 | 8.41 | 6.38 | 6.84 |
|
| 2-OC7H15 | B | 6.67 | 6.43 | 6.79 | 8.94 | 6.95 | 7.48 |
|
| 3-OC4H9 | B | 5.42 | 5.24 | 5.42 | 7.35 | 5.24 | 5.86 |
|
| 3-OC5H11 | B | 5.84 | 5.64 | 5.88 | 7.88 | 5.81 | 6.40 |
|
| 3-OC6H13 | B | 6.26 | 6.04 | 6.33 | 8.41 | 6.38 | 6.84 |
|
| 3-OC7H15 | B | 6.67 | 6.43 | 6.79 | 8.94 | 6.95 | 7.48 |
Values of logarithms of partition coefficients of basic (non-protonated) compounds 9′a–p predicted for the octan-1-ol/water partitioning system by the MLOGP, ACLOGP, miLogP 2.2, ALOGP, SILICOS-IT (log PS-IT) and ALOGPs 2.1 method, respectively.
| Comp. | MLOGP | ACLOGP | miLogP | ALOGP | log | ALOGPs |
|---|---|---|---|---|---|---|
|
| 2.75 | 5.05 | 5.30 | 5.42 | 4.27 | 5.18 |
|
| 2.96 | 5.52 | 5.80 | 5.87 | 4.68 | 5.57 |
|
| 3.16 | 5.98 | 6.32 | 6.33 | 5.10 | 5.93 |
|
| 3.36 | 6.45 | 6.81 | 6.79 | 5.53 | 6.25 |
|
| 2.75 | 5.05 | 5.32 | 5.42 | 4.27 | 5.21 |
|
| 2.96 | 5.52 | 5.83 | 5.87 | 4.68 | 5.61 |
|
| 3.16 | 5.98 | 6.33 | 6.33 | 5.10 | 5.95 |
|
| 3.36 | 6.45 | 6.84 | 6.79 | 5.53 | 6.32 |
|
| 3.16 | 5.69 | 6.31 | 6.33 | 4.78 | 5.93 |
|
| 3.36 | 6.16 | 6.81 | 6.79 | 5.20 | 6.23 |
|
| 3.56 | 6.62 | 7.32 | 7.24 | 5.62 | 6.54 |
|
| 3.76 | 7.08 | 7.82 | 7.70 | 6.04 | 6.77 |
|
| 3.16 | 5.69 | 6.33 | 6.33 | 4.78 | 5.97 |
|
| 3.36 | 6.16 | 6.84 | 6.79 | 5.20 | 6.27 |
|
| 3.56 | 6.62 | 7.34 | 7.24 | 5.62 | 6.59 |
|
| 3.76 | 7.08 | 7.85 | 7.70 | 6.04 | 6.83 |
Figure 4Two-dimensional biplot (mapping) showing both Principal Component 1 and 2 scores of the compounds 9′a–p and loadings of extrapolated chromatographic (log kw; 1a–p) and in silico lipophilicity variables, i.e., log PS-IT, XLOGP 2.0, XLOGP 3.0, ACLOGP, ALOGPs 2.1, miLogP 2.2, CLOGP 4.0, log PCr, log PV, log PB, MLOGP and ALOGP, respectively.
The in vitro activity (MIC values in μM units) of investigated compounds 1a–p and reference drugs isoniazid (INH), ethambutol (EMB), ofloxacin (OFLX) and ciprofloxacin (CPX) against M. tuberculosis CNCTC My 331/88 (M. tuberculosis H37Rv; MTv H37Rv), M. tuberculosis H37Ra ATCC 25177 (MTa H37Ra), M. kansasii CNCTC My 235/80 (MK 235/80), M. kansasii 6509/96 (MK 6509/96) and M. kansasii DSM 44162 (MK DSM), respectively.
| Comp. | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 14-d | 2 21-d | 3 7-d | 7-d | 14-d | 21-d | 7-d | 14-d | 21-d | 7-d | |
|
| 32 | 32 | 213 | 62.5 | 62.5 | 62.5 | 32 | 62.5 | 62.5 | 53 |
|
| 16 | 32 | 52 | 32 | 32 | 62.5 | 32 | 32 | 62.5 | 26.1 |
|
| 16 | 16 | 25 | 32 | 32 | 32 | 16 | 16 | 16 | 12.7 |
|
| 8 | 8 | 12.5 | 16 | 16 | 32 | 8 | 16 | 16 | 6.2 |
|
| 16 | 32 | 8.1 | 32 | 32 | 32 | 16 | 16 | 32 | 16.2 |
|
| 16 | 16 | <3.9 | 16 | 16 | 32 | 8 | 16 | 16 | 7.9 |
|
| 8 | 16 | <3.8 | 16 | 16 | 16 | 8 | 8 | 16 | 3.8 |
|
| 4 | 8 | <3.7 | 8 | 8 | 8 | 4 | 4 | 8 | 1.9 |
|
| 16 | 32 | 203 | 32 | 62.5 | 62.5 | 16 | 32 | 32 | 51 |
|
| 16 | 32 | 199 | 16 | 32 | 62.5 | 16 | 32 | 32 | 50 |
|
| 8 | 16 | 195 | 16 | 32 | 62.5 | 16 | 32 | 32 | 98 |
|
| 4 | 8 | 96 | 16 | 32 | 32 | 16 | 16 | 32 | 382 |
|
| 8 | 16 | 15.4 | 16 | 16 | 32 | 8 | 16 | 16 | 7.7 |
|
| 4 | 8 | 7.5 | 8 | 8 | 8 | 4 | 8 | 8 | 7.5 |
|
| 8 | 16 | 7.3 | 8 | 16 | 16 | 4 | 8 | 8 | 3.6 |
|
| 4 | 8 | 7.1 | 8 | 8 | 8 | 4 | 8 | 8 | 3.6 |
|
| 0.5 | 1 | 36.5 | >250 | >250 | >250 | 2 | 4 | 8 | 29.2 |
|
| 1 | 2 | – | – | – | – | 1 | 2 | 2 | – |
|
| 1 | 2 | – | 0.5 | 1 | 1 | 0.5 | 0.5 | 1 | – |
|
| – | – | 48.3 | – | – | – | – | – | – | 3.0 |
1 14-d, 14-Day cultivation; 2 21-d, 21-day cultivation; 3 7-d, 7-day cultivation. The most promising values of compounds in vitro antimycobacterial activity (MIC ≤ 8 μM) were indicated in gray cells of Table 6.
The in vitro activity (MIC values in μM units) of investigated compounds 1a–p and reference drugs isoniazid (INH), ethambutol (EMB), ofloxacin (OFLX) and ciprofloxacin (CPX) against M. avium CNCTC My 330/80 (MA 330/80), M. smegmatis ATCC 700084 (MS) and M. marinum CAMP 5644 (MM), respectively.
| Comp. | ||||
|---|---|---|---|---|
|
|
| |||
| 1 14-d | 2 21-d | 3 3-d | 21-d | |
|
| 125 | 125 | 213 | 106 |
|
| 62.5 | 125 | 104 | 52 |
|
| 32 | 62.5 | 51 | 25.5 |
|
| 32 | 32 | 24.9 | 12.5 |
|
| 62.5 | 62.5 | 16.2 | 32.5 |
|
| 32 | 32 | 15.8 | <3.9 |
|
| 16 | 16 | 15.4 | <3.8 |
|
| 8 | 16 | 15.0 | <3.7 |
|
| 62.5 | 125 | 203 | 51 |
|
| 62.5 | 125 | 6.2 | 50 |
|
| 32 | 62.5 | 390 | 98 |
|
| 32 | 62.5 | 382 | 191 |
|
| 16 | 32 | 30.7 | 15.4 |
|
| 16 | 16 | 15.0 | 15.0 |
|
| 16 | 16 | 7.3 | 7.3 |
|
| 16 | 16 | 7.1 | 7.1 |
|
| > 250 | > 250 | 117 | 467 |
|
| 16 | 16 | – | – |
|
| 32 | 62.5 | – | – |
|
| – | – | 0.4 | 0.8 |
1 14-d, 14-Day cultivation; 2 21-d, 21-day cultivation; 3 3-d, 3-day cultivation. The most promising values of compounds´ in vitro antimycobacterial activity (MIC ≤ 8 μM) were indicated in gray cells of Table 7.
Figure 5Chemical structure of the derivatives of 2-/3-alkoxyphenylcarbamic acids JC-02a–l (alkoxy = propoxy to octyloxy), which were in vitro screened against MTv H37Rv, MK 235/80, MK 6509/96 and MA 330/80 [76], respectively.
Figure 6Two-dimensional mapping of the loadings of variables (variously colored vectors) indicating their (i) positions towards a circle of correlation; and (ii) relationships to both Principal Component 1 and 2. Numbering of the vectors was as follows: 1 (the vector built on the log (1/MIC [M]) values, which were observed after 14-d in vitro cultivation against MTv H37Rv), 2 (MTv H37Rv, 21-d), 3 (MK 235/80, 7-d), 4 (MA 330/80, 14-d), 5 (MK 235/80, 21-d), 6 (MK 235/80, 14-d), 7 (MK 6509/96, 14-d), 8 (MK 6509/96, 7-d), 9 (MA 330/80, 21-d), 10 (MK 6509/96, 21-d), 11 (MTa H37Ra, 7-d), 12 (MM, 21-d), 13 (MK DSM, 7-d) and 14 (MS, 3-d), respectively.
Figure 7Bilinear relationship between the γ (in N/m units) and log (1/MIC [M]) parameters resulting from 21-d in vitro screening of the 3-alkoxy substituted compounds 1e–h and 1m–p (alkoxy = butoxy to heptyloxy) against MA 330/80.
Figure 8Bilinear relationship between the log kw and log (1/MIC [M]) parameters resulting from 21-d in vitro screening of the 3-alkoxy substituted compounds 1e–h and 1m–p (alkoxy = butoxy to heptyloxy) against MA 330/80.